• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Empowering Tanzanian journalists and researchers in science communication

Home > News

Empowering Tanzanian journalists and researchers in science communication

Group photo of participants from workshop
26 Feb 2024

DNDi collaborates with Ifakara Health Institute and SciDev to translate scientific research into engaging media stories 

On 20 February 2024, journalists and researchers joined a three-day communication workshop organized by the Ifakara Health Institute and DNDi, and conducted by SciDev, in Bagamoyo, Tanzania as part of the Helminth Elimination Platform (HELP) consortium. The media workshop was held to improve journalists’ and health reporters’ skills in reporting on neglected tropical diseases (NTDs) – particularly NTDs that are caused by worms.

Training sessions from Charles Wendo (left) and Sabine Specht (right)

Scientists and journalists often struggle to communicate complex research findings, making it difficult to keep the public informed of new developments and treatments that may benefit them. The aim of media workshops is to bridge the gap between scientists and journalists – allowing for broader public awareness of NTDs.

The three-day workshop brought together 12 scientists and 14 journalists to build synergies that can amplify the impact of health science stories, combat misinformation, and inspire positive change.

  • Man stands in front of a room of people with both hands raised
  • Workshop participants working in a group

Training sessions featured interactive workshops and hands-on activities designed to equip participants with the skills and knowledge to translate complex scientific findings into engaging news pieces. Highlights included sessions presented by Charles Wendo from SciDev.Net; Jennifer Keiser, Professor at Swiss Tropical and Public Health Institute and coordinator of the HELP consortium; and Sabine Specht, DNDi Head of Filarial Disease; as well as a ‘speed dating’ exercise matching journalists and researchers to inspire story ideas.

The final day of the workshop involved informative roundtable discussions between researchers and journalists that highlighted the importance of collaboration in education, health, and innovation in the fight to eliminate NTDs. Participants included Andrea Schenker-Wicki, President of the University of Basel; Conradin Cramer, Minister of Education for the Government of Kanton Basel-Stadt, Switzerland; Honorati Masanja, Chief Executive Director at Ifakara Health Institute; Lutz Hegemann, President of Global Health & Sustainability at Novartis; Jürg Utzinger, Director of the Swiss Tropical and Public Health Institute.

‘I was intrigued by the presentation on helminth infections and developed an interest in studies on worms and the connection between other diseases. It is important that we build connections with scientists for future interviews as key sources of information.’

Rachel Chacha, EFM radio

Michael Mihayo, Scientist at Ifakara Health Institute, highlighted the value of working closely with journalists in communicating research findings. ‘Sometimes scientists are hesitant to oversimplify their findings for fear of misrepresenting the research,’ he said.

  • A group of people stand in a laboratory
Participants of the workshop tour the Ifakara Health Institute facility

DNDi has been partnering with Swiss TPH and the HELP consortium to develop new treatments for river blindness (onchocerciasis) in Eastern Africa. Approximately 19 million people are living with river blindness, and 240 million people are at risk of contracting the disease.

About the HELP consortium

The Helminth Elimination Platform (HELP) consortium is a public-private partnership developing new drugs for helminth diseases, which are a debilitating group of diseases caused by parasitic worms including river blindness (onchocerciasis), lymphatic filariasis, as well as infection with roundworm, hookworm, and whipworm (soil-transmitted helminths).

Swiss Tropical and Public Health Institute leads the HELP consortium, which comprises research institutes, universities, not-for-profit organizations, and pharmaceutical companies including DNDi, Elanco, Ifakara Health Institute, Museum national d’Histoire naturelle, Universitätsklinikum Bonn, and University of Buea. The consortium is grateful for funding received from the European Union’s Horizon 2020 research and innovation programme

Photo credits: Saburi Ismail Seif – DNDi

Filaria: river blindness

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License